These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 7572110)
21. Performance of three-dimensional power Doppler angiography as third-step assessment in differential diagnosis of adnexal masses. Utrilla-Layna J; Alcázar JL; Aubá M; Laparte C; Olartecoechea B; Errasti T; Juez L; Mínguez JÁ; Guerriero S; Jurado M Ultrasound Obstet Gynecol; 2015 May; 45(5):613-7. PubMed ID: 25270368 [TBL] [Abstract][Full Text] [Related]
22. Three-dimensional ultrasonography and power Doppler in ovarian cancer screening of asymptomatic peri- and postmenopausal women. Kurjak A; Prka M; Arenas JM; Sparac V; Merce LT; Corusic A; Ivancic-Kosuta M Croat Med J; 2005 Oct; 46(5):757-64. PubMed ID: 16158468 [TBL] [Abstract][Full Text] [Related]
23. Pelvic examination, transvaginal ultrasound and transvaginal color Doppler sonography as predictors of ovarian cancer. Buckshee K; Temsu I; Bhatla N; Deka D Int J Gynaecol Obstet; 1998 Apr; 61(1):51-7. PubMed ID: 9622173 [TBL] [Abstract][Full Text] [Related]
24. [Usefulness of clinical evaluation for the level of CA-125 antigen and ultrasonographic color Doppler examination in diagnosis of ovarian tumor]. Czekierdowski A; Zrubek H; Sikorski M; Wiktor H; Józefczak M; Stachowicz N Ginekol Pol; 1996 Nov; 67(11):552-6. PubMed ID: 9289441 [TBL] [Abstract][Full Text] [Related]
25. Differential diagnosis of adnexal masses with transvaginal sonography, color flow imaging, and serum CA 125 assay in pre- and postmenopausal women. Strigini FA; Gadducci A; Del Bravo B; Ferdeghini M; Genazzani AR Gynecol Oncol; 1996 Apr; 61(1):68-72. PubMed ID: 8626120 [TBL] [Abstract][Full Text] [Related]
26. Pelvic examination, tumor marker level, and gray-scale and Doppler sonography in the prediction of pelvic cancer. Roman LD; Muderspach LI; Stein SM; Laifer-Narin S; Groshen S; Morrow CP Obstet Gynecol; 1997 Apr; 89(4):493-500. PubMed ID: 9083301 [TBL] [Abstract][Full Text] [Related]
27. Color Doppler ultrasound in the preoperative assessment of adnexal masses. Zanetta G; Vergani P; Lissoni A Acta Obstet Gynecol Scand; 1994 Sep; 73(8):637-41. PubMed ID: 7941989 [TBL] [Abstract][Full Text] [Related]
28. [Value of color Doppler ultrasonography, contrast-enhanced ultrasound and serum CA-125 detection in differential diagnosis of ovarian masses]. Zhou Q; Liu BL; Jiang J; Lei XY Nan Fang Yi Ke Da Xue Xue Bao; 2009 Oct; 29(10):2007-9. PubMed ID: 19861251 [TBL] [Abstract][Full Text] [Related]
29. Characterization of adnexal masses: combination of color Doppler and conventional sonography compared with spectral Doppler analysis alone and conventional sonography alone. Buy JN; Ghossain MA; Hugol D; Hassen K; Sciot C; Truc JB; Poitout P; Vadrot D AJR Am J Roentgenol; 1996 Feb; 166(2):385-93. PubMed ID: 8553953 [TBL] [Abstract][Full Text] [Related]
30. Pattern recognition of pelvic masses by gray-scale ultrasound imaging: the contribution of Doppler ultrasound. Valentin L Ultrasound Obstet Gynecol; 1999 Nov; 14(5):338-47. PubMed ID: 10623994 [TBL] [Abstract][Full Text] [Related]
31. Which extrauterine pelvic masses are difficult to correctly classify as benign or malignant on the basis of ultrasound findings and is there a way of making a correct diagnosis? Valentin L; Ameye L; Jurkovic D; Metzger U; Lécuru F; Van Huffel S; Timmerman D Ultrasound Obstet Gynecol; 2006 Apr; 27(4):438-44. PubMed ID: 16526098 [TBL] [Abstract][Full Text] [Related]
32. Color Doppler ultrasonography and serum CA 125 in the differentiation of benign and malignant ovarian tumors. Chou CY; Chang CH; Yao BL; Kuo HC J Clin Ultrasound; 1994 Oct; 22(8):491-6. PubMed ID: 7814654 [TBL] [Abstract][Full Text] [Related]
33. Preoperative detection of ovarian cancer by color Doppler ultrasonography and CA 125. Hossain F; Karim MN; Rahman SM; Khan N; Siddiqui M; Hussain R Bangladesh Med Res Counc Bull; 2010 Aug; 36(2):68-73. PubMed ID: 21473205 [TBL] [Abstract][Full Text] [Related]
34. [Role of pulsed color Doppler in the presurgical evaluation of pelvic masses]. Salle B; Gaucherand P; Ecochard R; Rudigoz RC J Gynecol Obstet Biol Reprod (Paris); 1995; 24(3):234-40. PubMed ID: 7622769 [TBL] [Abstract][Full Text] [Related]
35. Estimation of probability of malignancy using a logistic model combining physical examination, ultrasound, serum CA 125, and serum CA 72-4 in postmenopausal women with a pelvic mass: an international multicenter study. Schutter EM; Sohn C; Kristen P; Möbus V; Crombach G; Kaufmann M; Caffier H; Kreienberg R; Verstraeten AA; Kenemans P Gynecol Oncol; 1998 Apr; 69(1):56-63. PubMed ID: 9570999 [TBL] [Abstract][Full Text] [Related]
36. Colour and pulsed Doppler US and tumour marker CA 125 in differentiation between benign and malignant ovarian masses. Antonić J; Rakar S Anticancer Res; 1995; 15(4):1527-32. PubMed ID: 7654041 [TBL] [Abstract][Full Text] [Related]
37. Estimation of probability of malignancy using a logistic model combining color Doppler ultrasonography, serum CA125 level in women with a pelvic mass. Mousavi AS; Borna S; Moeinoddini S Int J Gynecol Cancer; 2006; 16 Suppl 1():92-8. PubMed ID: 16515574 [TBL] [Abstract][Full Text] [Related]
38. The risk of malignancy index in discrimination of adnexal masses. Ulusoy S; Akbayir O; Numanoglu C; Ulusoy N; Odabas E; Gulkilik A Int J Gynaecol Obstet; 2007 Mar; 96(3):186-91. PubMed ID: 17280665 [TBL] [Abstract][Full Text] [Related]
39. Sonographic discrimination between benign and malignant adnexal masses in premenopause. Radosa MP; Vorwergk J; Fitzgerald J; Kaehler C; Schneider U; Camara O; Runnebaum IB; Schleußner E Ultraschall Med; 2014 Aug; 35(4):339-44. PubMed ID: 23775448 [TBL] [Abstract][Full Text] [Related]
40. Blood flow characteristics of ovarian tumors: implications for ovarian cancer screening. Carter JR; Lau M; Fowler JM; Carlson JW; Carson LF; Twiggs LB Am J Obstet Gynecol; 1995 Mar; 172(3):901-7. PubMed ID: 7892883 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]